Similar articles

• Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms.

  Abisi S, Burnand KG, Humphries J, Waltham M, Taylor P, Smith A. Abisi S, et al. Br J Surg. 2008 Mar;95(3):333-7. doi: 10.1002/bjs.5989. Br J Surg. 2008. PMID: 17968978
• HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms.

  Wilson WR, Evans J, Bell PR, Thompson MM. Wilson WR, et al. Eur J Vasc Endovasc Surg. 2005 Sep;30(3):259-62. doi: 10.1016/j.ejvs.2005.02.044. Eur J Vasc Endovasc Surg. 2005. PMID: 16009575
• Distribution, activity and concentration of cathepsin B and cystatin C in the wall of aortic aneurysm.

  Gacko M, Chyczewski L, Chrostek L. Gacko M, et al. Pol J Pathol. 1999;50(2):83-6. Pol J Pathol. 1999. PMID: 10481531
• Pharmacological treatment of abdominal aortic aneurysm.

  Miyake T, Morishita R. Miyake T, et al. Cardiovasc Res. 2009 Aug 1;83(3):436-43. doi: 10.1093/cvr/cvp155. Epub 2009 May 19. Cardiovasc Res. 2009. PMID: 19454489 Review.
• Effect of statins on abdominal aortic aneurysm.

  Hosseini A, Sahranavard T, Reiner Ž, Jamialahmadi T, Dhaheri YA, Eid AH, Sahebkar A. Hosseini A, et al. Eur J Pharm Sci. 2022 Nov 1;178:106284. doi: 10.1016/j.ejps.2022.106284. Epub 2022 Aug 26. Eur J Pharm Sci. 2022. PMID: 36038100 Review.